This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) has conducted the world's first and largest genetic association study of age at diagnosis of type 2 diabetes in a Chinese population. The study identified three genetic regions associated with younger disease onset, impaired insulin-producing beta-cell function, and poorer blood glucose control.
Based on the distinct genetic markers, the multidisciplinary team pioneered an innovative Age-at-Diabetes-Diagnosis Genetic Risk Score (ADD-GRS) capable of early, low-cost identification of high-risk Chinese individuals, paving the way for more precise prevention and personalized intervention.
Diabetes affects one in every nine adults worldwide and was the 10th leading cause of death in Hong Kong in 2025. Type 2 diabetes, the most common form of diabetes, occurs when the body cannot produce or use insulin effectively, leading to high blood glucose. Insulin, the only hormone that lowers blood glucose levels, is exclusively produced and released by the beta-cells in the pancreas.
In Asia, young-onset diabetes, diagnosed before the age of 40, accounts for one in five type 2 diabetes cases, a prevalence twice that observed in European populations. Compared with later-onset diabetes, it is associated with faster beta-cell function decline and longer high blood glucose exposure.
The prolonged condition damages blood vessels and multiple organs, raising the premature death risk by four- to ninefold compared with peers without diabetes. Diabetes arises from complex interactions among genetic, life-course and environmental factors.
Source link







